- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03584932
Youth Services Navigation Intervention for HIV+ Youth Being Released From or At-risk for Incarceration (LINK2)
Youth Services Navigation Intervention for HIV+ Adolescents and Young Adults Being Released From or at Risk for Incarceration: A Randomized Control Trial
HIV prevalence among incarcerated youth living with HIV (YWH) is three times that of the general population and one in seven of all persons with HIV experience incarceration each year. Furthermore, less than half of all youth in the United States with HIV achieve HIV viral load suppression, due to poor retention and adherence to anti-retroviral therapy (ART). Existing linkage and retention services are insufficient to meet the acute needs of youth with HIV who are at risk for incarceration, recently experienced incarceration or arrest, or those nearing reentry from a correctional facility. This holds particularly true in the high-need period following release from incarceration. The LINK2 study will develop and implement a youth service navigation (YSN) intervention to improve linkage and retention among YWH at risk for incarceration and with current incarceration and arrest histories and analyze results to address existing gaps in the literature.
The investigators will enroll 142 YWH, aged 16-25 (+364 days), incarcerated in Los Angeles and Chicago jails and through community providers serving those at risk for incarceration and YWH with recent incarceration and arrest histories. The investigators will randomize participants to the YSN intervention (n=71) vs. a usual-care control group (n=71). The youth services navigators (YSNs) will assist with addressing immediate unmet needs such as housing, transportation, and food prior to clinical care and ongoing; will guide intervention participants to a range of community services to support progress along the continuum of HIV care; and will provide direct ART adherence support.
The proposed study has two Primary Specific Aims:
- Adapt an existing peer navigation intervention for adults to create a Youth Service Navigation (YSN) intervention sensitive to sexual and gender minority (SGM) culture that guides youth to needed services along the continuum of HIV care. This intervention combines medical, substance use and mental health care with comprehensive reentry support for YWH, aged 16-25 (+364 days) upon release from large county jails and juvenile detention systems or with arrests in the prior 12 months and those at risk for incarceration based on various social determinants.
- Using a two-group RCT design, the investigators will test the effectiveness of the new YSN, youth SGM-sensitive intervention among YLWH aged 16-25 (+364 days), compared to controls offered standard of care. The investigators will evaluate the YSN Intervention's effect on post-incarceration linkage, retention, adherence, and viral suppression, as well as on substance use disorders, mental health, services utilization, and met needs. Secondary Aims: The investigators will assess YSN's effects on recidivism, costs and potential cost-offset/effectiveness.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
If recruited in jail:
- Diagnosed HIV+;
- at least 18 but younger than 26 (25 and 364 days);
- non-cis women;
- Fluent in speaking English;
- Have an anticipated sentence of no more than 12 months;
- Going to live in the State of Illinois, LA County, Kern County, San Diego County, Riverside County, Ventura County or San Bernardino County
If recruited outside of jail:
1) Diagnosed HIV+; 2) At least 16 but younger than 26 (25 and 364 days); 3) Non-cis women; 4) Fluent in speaking English; 5) Incarceration or arrest history within the last 12 months of enrollment; or 6) At risk for incarceration defined as having one or more of the following risk factors: mental illness, substance use disorder, current financial hardship, homelessness, unstable housing in the prior 6 months, foster care or parental incarceration; 7) Living in the State of Illinois, LA County, Kern County, San Diego County, Riverside County, Ventura County or San Bernardino County
Exclusion Criteria:
1. Inability to give informed consent; 2. Parole hold or transfer to prison
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention arm
Subjects participate in a youth service navigation intervention and are eligible to receive contingency management incentives.
|
There will be 6 in-person sessions delivered by a youth services navigator, plus weekly check-in calls after session 2 for a total of six months.
As part of the learning sessions, the participant will learn important information about HIV and how to get the most out of his/her HIV care.
|
No Intervention: Control arm
Standard of care as set forth by the national HIV care guidelines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Linkage to HIV care, retention in HIV, adherence to anti-retroviral therapy (ART), and viral suppression
Time Frame: 12 months
|
Linkage to care HIV care is measured as HIV primary care provider visits; time to 1st post-release HIV care visit.
Measures will involve survey and electronic record sources; self-reported measures derived from Outreach Initiative and HCSUS instrument.
Retention in HIV care is measured as number of visits and missed visits to HIV primary care providers.
Measurement tools include surveys and electronic record sources; self-reported measures derived from the Outreach Initiative and the HCSUS instrument.
ART adherence is measured using a visual analogue scale of % (0-100) in surveys.
Additional tools include electronic record sources; self-reported measures derived from Outreach Initiative; HCSUS instrument.
Viral suppression is deemed undetectable at < 50 copies/ml as defined by the Los Angeles County Department of Public Health.
Tools will include survey and electronic record sources and items from the HCSUS instrument and Outreach Initiative.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effects on recidivism, costs and potential cost-offset/effectiveness
Time Frame: 5 years
|
Cost offsets/effectiveness will be measured as number of outpatient HIV/general primary and specialty care; number of mental health and substance abuse treatment visits and stays.
Measures will involve electronic data sets for outpatient HIV primary and specialty care; and data sets for mental health and substance abuse treatment visits/stays.
|
5 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- Urogenital Diseases
- Genital Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- R01MD011773-02 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on LINK2 Youth Services Navigation Intervention
-
University of CalgaryAlberta Innovates Health Solutions; Canadian Diabetes AssociationActive, not recruitingHypertension | Diabetes Mellitus, Type 2 | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Asthma | Ischemic Heart Disease | Congestive Heart FailureCanada
-
San Diego State UniversityNational Institute of Mental Health (NIMH)Completed
-
San Diego State UniversityNational Institute of Mental Health (NIMH)Completed
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingHIV Pre-Exposure ProphylaxisUnited States
-
San Diego State UniversityNational Institute of Mental Health (NIMH)RecruitingSuicideUnited States
-
University of UtahCenters for Medicare and Medicaid Services; Sletten Cancer InstituteCompletedCervical Cancer | Breast Cancer | Colorectal Cancer | Lung Cancer | Prostate CancerUnited States
-
University of OregonNational Institute on Drug Abuse (NIDA); Oregon Social Learning CenterCompletedRisk Behavior | Sexual Behavior | Drug Use | Adolescent Behavior | Juvenile Delinquency UnspecifiedUnited States
-
University of ConnecticutMercer UniversityCompleted
-
University of Texas Southwestern Medical CenterMichael E. DeBakey VA Medical Center; Parkland Health and Hospital SystemCompletedCarcinoma, Hepatocellular | Liver NeoplasmsUnited States
-
London School of Hygiene and Tropical MedicineEuropean Commission; Development Cooperation Ireland (previously known as Ireland...CompletedHIV Infections | Sexually Transmitted Diseases | Pregnancy | Sexual BehaviorTanzania